Trial intelligence / Profile preview

COMPASS: Atorvastatin vs Pravastatin for Neointimal Pattern in DES

NCT02155530Completed

Sponsor
Yonsei University
Start
Jun 2014
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of atorvastatin in coronary artery disease (CAD) (2 arms), sponsored by Yonsei University. Primary endpoint: Change of neointimal patterns assessed by 1-year followed OCT. Started Jun 2014; status: completed.

02

Drugs

atorvastatin
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02155530.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02155530.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call